Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04514874
Previous Study | Return to List | Next Study

Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020 (Covaé)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04514874
Recruitment Status : Completed
First Posted : August 17, 2020
Last Update Posted : March 9, 2021
Sponsor:
Information provided by (Responsible Party):
Direction Centrale du Service de Santé des Armées

Brief Summary:
The aeronautical community was also affected and greatly impacted economically and socially by the Covid-19 pandemic. Away from the acute phase, the epidemiological impact and the consequences of this disease within the French aviation flight crew population must be assessed. This study is aimed at providing original epidemiological data among civil and military aircrew, prior to possible prevention strategies or countermeasures to optimize risk management in terms of aviation safety and to promote, if necessary, future targeted studies.

Condition or disease Intervention/treatment
Covid19 SARS-CoV Infection Other: Questionnaire

Layout table for study information
Study Type : Observational
Actual Enrollment : 479 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020
Actual Study Start Date : September 1, 2020
Actual Primary Completion Date : October 5, 2020
Actual Study Completion Date : October 5, 2020

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: Questionnaire
    Self-questionnaire about socio-demographical status, health status and lifestyle habits during and following the COVID-19 pandemic.


Primary Outcome Measures :
  1. Prevalence of COVID-19 infection among French military professional aircrew [ Time Frame: At enrollment ]
    Prevalence of COVID-19 infection will be estimated on the basis of the replies to the questionnaire


Secondary Outcome Measures :
  1. Predictive factors of COVID-19 infection [ Time Frame: At enrollment ]
    Predictive factors of COVID-19 infection will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.

  2. Techniques used for COVID-19 screening [ Time Frame: At enrollment ]
    Techniques used for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)

  3. Reasons for COVID-19 screening [ Time Frame: At enrollment ]
    Reasons for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)

  4. Experienced symptoms of COVID-19 [ Time Frame: At enrollment ]
    Experienced symptoms of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)

  5. Medical care of COVID-19 [ Time Frame: At enrollment ]
    Medical care of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)

  6. Social consequences of the COVID-19 pandemic [ Time Frame: At enrollment ]
    Social consequences of the COVID-19 pandemic will be estimated on the basis of the replies to the questionnaire

  7. Factors associated with pejorative consequences of the COVID-19 pandemic [ Time Frame: At enrollment ]
    Factors associated with pejorative consequences of the COVID-19 pandemic will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The study population will be composed of professional military aircrew of all aeronautical specialties presenting themselves for a periodic medical exam.
Criteria

Inclusion Criteria:

  • At least 18 years of age
  • Professional military aircrew
  • Presenting himself/herself for a periodic medical exam

Exclusion Criteria:

  • Under 18 years of age
  • Parachutists
  • Non-professional aircrew
  • Presenting himself/herself for a first medical exam
  • Pregnant woman, parturient, breastfeeding

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04514874


Locations
Layout table for location information
France
Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Percy
Clamart, France, 92140
Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Sainte-Anne
Toulon, France, 83000
Sponsors and Collaborators
Direction Centrale du Service de Santé des Armées
Layout table for additonal information
Responsible Party: Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier: NCT04514874    
Other Study ID Numbers: 2020-COVID19-26
2020-A01459-30 ( Other Identifier: IDRCB )
First Posted: August 17, 2020    Key Record Dates
Last Update Posted: March 9, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Severe Acute Respiratory Syndrome
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases